Cell Line and Augument Cellular Uptake Study of Statistically Optimized Sustained Release Capecitabine Loaded Eudragit S100/PLGA(poly(lacticco- glycolic acid)) Nanoparticles for Colon Targeting.

Background: Capecitabine, an anti cancer drug, has a very short drug elimination half-life (0.49 to 0.89 h).